Is C-reactive protein sufficient to guide antimicrobial therapy for lower respiratory tract infections among children? Results from a stepped-wedge cluster randomized trial in Uganda

PLoS Med. 2024 Sep 17;21(9):e1004467. doi: 10.1371/journal.pmed.1004467. eCollection 2024 Sep.
No abstract available

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Anti-Infective Agents / therapeutic use
  • C-Reactive Protein* / analysis
  • C-Reactive Protein* / metabolism
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Male
  • Respiratory Tract Infections* / drug therapy
  • Uganda / epidemiology

Substances

  • C-Reactive Protein
  • Anti-Bacterial Agents
  • Anti-Infective Agents

Grants and funding

The author(s) received no specific funding for this work.